Page last updated: 2024-10-26

dipyridamole and Dyspnea

dipyridamole has been researched along with Dyspnea in 14 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"We report a fatal case of airway obstruction caused by spontaneous retropharyngeal hematoma (RH) in the setting of treatment with dipyridamole."7.96Fatal Spontaneous Retropharyngeal Hematoma with Airway Obstruction in the Setting of Treatment with Dipyridamole. ( Chiba, F; Iwase, H; Makino, Y; Torimitsu, S; Tsuneya, S; Yamaguchi, R, 2020)
"We report a fatal case of airway obstruction caused by spontaneous retropharyngeal hematoma (RH) in the setting of treatment with dipyridamole."3.96Fatal Spontaneous Retropharyngeal Hematoma with Airway Obstruction in the Setting of Treatment with Dipyridamole. ( Chiba, F; Iwase, H; Makino, Y; Torimitsu, S; Tsuneya, S; Yamaguchi, R, 2020)
"Dipyridamole was associated with fewer adverse events than regadenoson in patients undergoing MPI."1.46Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging. ( Amer, KA; Cohen, G; Edwin, SB; Hurren, JR, 2017)
"Patients with end-stage chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS) are at high risk of peri-operative cardiac complications, and myocardial perfusion scintigraphy (MPS) is commonly used for risk stratification."1.31The safety of dipyridamole in patients undergoing myocardial perfusion scintigraphy prior to lung volume reduction surgery. ( Angelides, S; da Silva, I; Freeman, AP; Parker, MK; Roman, MR, 2001)
"A clinical diagnosis of thrombotic thrombocytopenic purpura (TTP) was made."1.30A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura. ( Arase, S; Horie, T; Miyaoka, Y; Nameda, Y; Sano, N; Shigekiyo, T; Urano, Y, 1997)
" The test was found to be safe for patients over 70 yr old."1.28Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease. ( Perper, EJ; Segall, GM, 1991)
"Dyspnea was noted in 80 cases (40."1.27[How dangerous is the dipyridamole test?]. ( Bramann, HU; Görtz, P; Grosse-Heitmeyer, W; Mönninghoff, W; Most, E; St Müller, U, 1983)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's7 (50.00)18.2507
2000's2 (14.29)29.6817
2010's2 (14.29)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Torimitsu, S1
Makino, Y1
Yamaguchi, R1
Chiba, F1
Tsuneya, S1
Iwase, H1
Amer, KA1
Hurren, JR1
Edwin, SB1
Cohen, G1
Maron, BA1
Shekar, PS1
Goldhaber, SZ1
GADDY, CG1
Chen, ML1
Lo, HS1
Chao, IM1
Su, HY1
Grosse-Heitmeyer, W1
Bramann, HU1
Görtz, P1
Mönninghoff, W1
St Müller, U1
Most, E1
D'Angelo, M1
Simonelli, P1
Del Mastro, L1
Auriemma, F1
Abate, R1
Vetrano, A1
Olatidoye, AG1
Baltazar, RF1
Leitha, T1
Gwechenberger, M1
Falger-Banyai, S1
Miyaoka, Y1
Urano, Y1
Nameda, Y1
Shigekiyo, T1
Horie, T1
Sano, N1
Arase, S1
Herlitz, J1
Haglid, M1
Hartford, M1
Karlson, BW1
Karlsson, T1
Lindelöw, B1
Caidahl, K1
Thurnheer, R1
Laube, I1
Kaufmann, PA1
Stumpe, KD1
Stammberger, U1
Bloch, KE1
Weder, W1
Russi, EW1
Roman, MR1
Angelides, S1
Freeman, AP1
Parker, MK1
da Silva, I1
Perper, EJ1
Segall, GM1

Other Studies

14 other studies available for dipyridamole and Dyspnea

ArticleYear
Fatal Spontaneous Retropharyngeal Hematoma with Airway Obstruction in the Setting of Treatment with Dipyridamole.
    Journal of forensic sciences, 2020, Volume: 65, Issue:3

    Topics: Aged, 80 and over; Airway Obstruction; Dipyridamole; Dyspnea; Ecchymosis; Female; Heart Arrest; Hema

2020
Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Pharmacotherapy, 2017, Volume: 37, Issue:6

    Topics: Adenosine A2 Receptor Agonists; Aged; Cohort Studies; Cost-Benefit Analysis; Dipyridamole; Dyspnea;

2017
Paradoxical embolism.
    Circulation, 2010, Nov-09, Volume: 122, Issue:19

    Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Dyspnea; Echocardiography, Transesophageal; Embolism, Para

2010
LONG-TERM TREATMENT OF MYOCARDIAL ISCHEMIA.
    Virginia medical monthly, 1964, Volume: 91

    Topics: Angina Pectoris; Coronary Artery Disease; Dipyridamole; Dyspnea; Exercise Test; Fatigue; Humans; Myo

1964
Dipyridamole Tl-201 myocardial single photon emission computed tomography in the functional assessment of anomalous left coronary artery from the pulmonary artery.
    Clinical nuclear medicine, 2007, Volume: 32, Issue:12

    Topics: Adolescent; Angina Pectoris; Blood Vessel Prosthesis Implantation; Cineangiography; Coronary Circula

2007
[How dangerous is the dipyridamole test?].
    Zeitschrift fur Kardiologie, 1983, Volume: 72, Issue:6

    Topics: Adult; Aged; Aminophylline; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes

1983
[Safety of the dipyramidole echocardiography test in elderly coronary disease patients].
    Minerva cardioangiologica, 1993, Volume: 41, Issue:5

    Topics: Age Factors; Aged; Angina, Unstable; Coronary Disease; Dipyridamole; Dose-Response Relationship, Dru

1993
Dipyridamole-thallium stress testing: a local community hospital experience.
    Maryland medical journal (Baltimore, Md. : 1985), 1993, Volume: 42, Issue:7

    Topics: Aged; Aged, 80 and over; Clinical Protocols; Coronary Disease; Dipyridamole; Dyspnea; Electrocardiog

1993
Does dyspnoea during dipyridamole cardiac stress testing indicate bronchospasm and is the pretest clinical history predictive of this side-effect?
    European journal of nuclear medicine, 1995, Volume: 22, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Bronchial Spasm; Dipyridamole; Dyspnea; Exercise Test; Female; Human

1995
A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:1

    Topics: Anti-Inflammatory Agents; Dermatomyositis; Dipyridamole; Dyspnea; Epoprostenol; Fatal Outcome; Fever

1997
Physical activity, dyspnea, and chest pain before and after coronary artery bypass grafting in relation to a history of diabetes.
    Diabetes care, 1998, Volume: 21, Issue:10

    Topics: Activities of Daily Living; Aspirin; Chest Pain; Coronary Artery Bypass; Diabetic Angiopathies; Dipy

1998
Practicability and safety of dipyridamole cardiac imaging in patients with severe chronic obstructive pulmonary disease.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:8

    Topics: Ammonia; Bronchoconstriction; Coronary Disease; Dipyridamole; Dyspnea; Female; Heart; Humans; Lung D

1999
The safety of dipyridamole in patients undergoing myocardial perfusion scintigraphy prior to lung volume reduction surgery.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:9

    Topics: Aged; Aged, 80 and over; Aminophylline; Bronchodilator Agents; Dipyridamole; Dyspnea; Exercise Test;

2001
Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:11

    Topics: Age Factors; Cardiac Catheterization; Chest Pain; Contraindications; Coronary Disease; Dipyridamole;

1991